Skip to main content
Top
Published in: Abdominal Radiology 2/2018

01-02-2018

Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma

Authors: Anushri Parakh, Manuel Patino, Daniela Muenzel, Avinash Kambadakone, Dushyant V. Sahani

Published in: Abdominal Radiology | Issue 2/2018

Login to get access

Abstract

Purpose

The purpose of this study is to evaluate the performance of material-specific iodine (MS-I) images generated by rapid kV-switching single-source dual-energy computed tomography (rsDECT) for distinguishing post-operative changes from local tumor recurrence in patients on follow-up for pancreatic adenocarcinoma after surgical resection.

Methods

In this IRB-approved HIPPA-compliant study, retrospective review of 51 patients who underwent surgical resection of pancreatic adenocarcinoma was conducted and were followed up using contrast-enhanced rsDECT (Discovery CT 750HD, GE Healthcare, Milwaukee, WI). Independent qualitative assessment for presence of local tumor recurrence was performed by two radiologists who evaluated 65 keV (single-energy CT-equivalent interpretation) and 65 keV with MS-I (rsDECT interpretation) in separate sessions. Quantitative analysis of Hounsfield unit (HU, on 65 keV) and normalized iodine concentration (NIC on MS-I images; iodine concentration ratio in post-operative tissue to aorta) was measured. Follow-up imaging, temporal change of CEA and CA 19-9 or biopsy served as reference standard for presence and absence of local recurrence. Sensitivity and specificity of readers and quantitative parameters was calculated and receiver operating characteristic curves and Fisher’s exact test were generated. A p value < 0.05 was considered statistically significant.

Results

A total of 51 patients (27 females, 24 males) with mean age of 64 years built the final cohort. Local recurrence was absent in 23 (Group A) and present in 28 (Group B) patients. The follow-up imaging was performed within 7 months of rsDECT. For both readers, the addition of MS-I increased the specificity for tissue characterization and improved reader confidence as compared to 65 keV (specificity: 80% and 56%, respectively) images alone. Quantitative analysis revealed a significantly lower NIC (0.28 vs. 0.35; p < 0.05) for non-recurrent tissue. However, HU was not significantly different for non-recurrent and recurrent tissue (0.63 vs. 0.70; p > 0.05).

Conclusion

In inherently complex cases of post-operative pancreatic adenocarcinoma, MS-I images from rsDECT can be a useful adjunct to conventional scans in characterizing loco-regional soft tissue.
Literature
7.
go back to reference Wilkowski R, Thoma M, Bruns C, Dühmke E, Heinemann V (2006) Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 7(1):34–40PubMed Wilkowski R, Thoma M, Bruns C, Dühmke E, Heinemann V (2006) Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 7(1):34–40PubMed
10.
go back to reference Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21(2):195–200CrossRefPubMed Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21(2):195–200CrossRefPubMed
15.
go back to reference Yamauchi H, Buehler M, Goodsitt MM, Keshavarzi N, Srinivasan A (2016) Dual-energy CT-based differentiation of benign posttreatment changes from primary or recurrent malignancy of the head and neck: comparison of spectral Hounsfield units at 40 and 70 keV and iodine concentration. Am J Roentgenol 206(3):580–587. https://doi.org/10.2214/AJR.15.14896 CrossRef Yamauchi H, Buehler M, Goodsitt MM, Keshavarzi N, Srinivasan A (2016) Dual-energy CT-based differentiation of benign posttreatment changes from primary or recurrent malignancy of the head and neck: comparison of spectral Hounsfield units at 40 and 70 keV and iodine concentration. Am J Roentgenol 206(3):580–587. https://​doi.​org/​10.​2214/​AJR.​15.​14896 CrossRef
25.
go back to reference Jadvar H, Fischman AJ (2001) Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging 26(3):254–259CrossRefPubMed Jadvar H, Fischman AJ (2001) Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging 26(3):254–259CrossRefPubMed
27.
go back to reference Diederichs CG, Staib L, Glasbrenner B, et al. (1999) F-18 fluorodeoxyglucose (FDG) and C-reactive protein (CRP). Clin Positron Imaging 2(3):131–136CrossRefPubMed Diederichs CG, Staib L, Glasbrenner B, et al. (1999) F-18 fluorodeoxyglucose (FDG) and C-reactive protein (CRP). Clin Positron Imaging 2(3):131–136CrossRefPubMed
34.
go back to reference Stiller W, Skornitzke S, Fritz F, et al. (2015) Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion? Investig Radiol 50(10):703–708. https://doi.org/10.1097/RLI.0000000000000176 CrossRef Stiller W, Skornitzke S, Fritz F, et al. (2015) Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion? Investig Radiol 50(10):703–708. https://​doi.​org/​10.​1097/​RLI.​0000000000000176​ CrossRef
36.
go back to reference Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W (2011) Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics 31(4):1031–1046; discussion 1047–1050. 10.1148/rg.314105159 Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W (2011) Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics 31(4):1031–1046; discussion 1047–1050. 10.​1148/​rg.​314105159
Metadata
Title
Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma
Authors
Anushri Parakh
Manuel Patino
Daniela Muenzel
Avinash Kambadakone
Dushyant V. Sahani
Publication date
01-02-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1390-2

Other articles of this Issue 2/2018

Abdominal Radiology 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.